Zhejiang Gongdong Medical Technology Co.,Ltd. (SH: 605369) has released its semi-annual report for fiscal year 2026, showing operating revenue of RMB 588 million for the reporting period, representing a year-on-year increase of 5.58%.
The company's net profit attributable to shareholders of the listed company reached RMB 54.6923 million, up 8.63% from the same period last year. However, net profit attributable to shareholders after deducting non-recurring gains and losses stood at RMB 53.0738 million, reflecting a decline of 11.18% year-on-year, with basic earnings per share at RMB 0.25.
The 8.63% growth in net profit attributable to shareholders during the period was primarily driven by increased operating revenue, which correspondingly boosted the absolute amount of gross profit. Additionally, the company implemented business optimization initiatives for its TPI segment, which led to a notable recovery in its profitability. These factors collectively contributed to the improvement in net profit attributable to the parent company's shareholders for the period.
- Like
- Comment
- Favorite
Gongdong Medical Reports First-Half Net Profit of RMB 54.69 Million, Up 8.63% Year-On-Year
Stock News08-24
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Like
Report
Login to post
No comments yet